In order to examine the prognostic significance of miR-33a in patients with hepatocellular carcinoma (HCC), total RNA was extracted from 149 HCC biopsies, 36 of which were paired with para-carcinoma tissues, and miR-33a expression was measured by reverse transcription-quantitative polymerase chain reaction. The results demonstrated that miR-33a expression was decreased in HCC biopsies compared with normal liver tissue samples. It was also demonstrated that miR-33a expression was significantly associated with tumor foci number. Furthermore, overall and progression-free survival time was decreased in patients expressing low miR-33a with multiple tumor foci. Taken together, the low expression of miR-33a may be a potential risk factor for HCC.
MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.
Ru-ting Xie,Xianling Cong,Xiaoming Zhong,P. Luo,Huiqiong Yang,Gaixia Lu,P. Luo,Zhengyan Chang,R. Sun,Tingmiao Wu,Zhongwei Lv,D. Fu,Yushui Ma
Published 2018 in Oncology Letters
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Oncology Letters
- Publication date
2018-04-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-48 of 48 references · Page 1 of 1
CITED BY
Showing 1-23 of 23 citing papers · Page 1 of 1